{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:38:10Z","timestamp":1774283890289,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T00:00:00Z","timestamp":1187049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s12032-007-0036-6","type":"journal-article","created":{"date-parts":[[2007,8,13]],"date-time":"2007-08-13T16:56:07Z","timestamp":1187024167000},"page":"30-39","source":"Crossref","is-referenced-by-count":38,"title":["Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and -negative leukemia cells"],"prefix":"10.1007","volume":"25","author":[{"given":"S.","family":"Harakeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Abu-El-Ardat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Diab-Assaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Niedzwiecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"El-Sabban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,14]]},"reference":[{"key":"36_CR1","doi-asserted-by":"crossref","DOI":"10.1201\/9780203907993","volume-title":"Green tea: health benefits and applications","author":"Y Hare","year":"2001","unstructured":"Hare Y. Green tea: health benefits and applications. New York: Marcel Dekker, Basel; 2001."},{"key":"36_CR2","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/jn\/129.12.2130","volume":"129","author":"D Erba","year":"1999","unstructured":"Erba D, Riso P, Colombo A, Testolin G. Supplementation of Jurkat T cells with green tea extract decreases oxidative damage due to iron treatment. J Nutr 1999;129:2130\u20134.","journal-title":"J Nutr"},{"key":"36_CR3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0091-6749(03)02007-4","volume":"112","author":"K Kawai","year":"2003","unstructured":"Kawai K, et al. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp 120 binding. J Allergy Clin Immunol 2003;112:951\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"36_CR4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1006\/bbrc.2001.5293","volume":"285","author":"S Hayakawa","year":"2001","unstructured":"Hayakawa S, et al. Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem Biophys Res Commun 2001;285:1102\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"36_CR5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/abbi.2000.1742","volume":"376","author":"N Ahmad","year":"2000","unstructured":"Ahmad N, Gupta S, Mukhtar H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor \u03baB in cancer cells versus normal cells. Arch Biochem Biophys 2000;376:338\u201346.","journal-title":"Arch Biochem Biophys"},{"key":"36_CR6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/taap.1999.8885","volume":"164","author":"S Gupta","year":"2000","unstructured":"Gupta S, Ahmad N, Nieminen AL, Mukhtar H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 2000;164:82\u201390.","journal-title":"Toxicol Appl Pharmacol"},{"key":"36_CR7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0027-5107(97)00310-2","volume":"402","author":"HJ Fujiki","year":"1998","unstructured":"Fujiki HJ, et al. Cancer inhibition by green tea. Mutation Res 1998;402:307\u201310.","journal-title":"Mutation Res"},{"key":"36_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s007260200002","volume":"22","author":"YC Wang","year":"2002","unstructured":"Wang YC, Bachrach U. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG). Amino Acids 2002;22:131\u201343.","journal-title":"Amino Acids"},{"key":"36_CR9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1349-7006.2000.tb00857.x","volume":"91","author":"H Li","year":"2000","unstructured":"Li H, et al. Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T-cell leukemia patients. Jpn J Cancer Res 2000;91:34\u201340.","journal-title":"Jpn J Cancer Res"},{"key":"36_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0027-5107(02)00319-6","volume":"523\u2013524","author":"M Roy","year":"2003","unstructured":"Roy M, Chakrabarty S, Sinha D, Bhattacharya R, Siddiqi M. Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: a green tea polyphenol. Mutation Res 2003;523\u2013524:33\u201341.","journal-title":"Mutation Res"},{"key":"36_CR11","first-page":"253","volume":"13","author":"MW Roomi","year":"2005","unstructured":"Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing\u2019s Sarcoma SK-ES.1. Oncol Rep 2005;13:253\u20137.","journal-title":"Oncol Rep"},{"key":"36_CR12","first-page":"179","volume":"19","author":"MW Roomi","year":"2005","unstructured":"Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. In Vivo 2005;19:179\u201383.","journal-title":"In Vivo"},{"key":"36_CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1385\/MO:22:2:129","volume":"22","author":"MW Roomi","year":"2005","unstructured":"Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, acorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7. Med Oncol 2005;22:129\u201338.","journal-title":"Med Oncol"},{"key":"36_CR14","first-page":"1371","volume":"66","author":"Y Hinuma","year":"1985","unstructured":"Hinuma Y, et al. Transforming genes in human leukemia cells. PNAS 1985;66:1371\u20138.","journal-title":"PNAS"},{"key":"36_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/rmv.1980030304","volume":"3","author":"J Kaplan","year":"1993","unstructured":"Kaplan J, Khabbaz R. The epidemiology of human T-lymphotropic virus type I and II. Med Virol 1993;3:137\u201348.","journal-title":"Med Virol"},{"key":"36_CR16","unstructured":"Gessain A. Epidemiology of HTLV-1 and associated diseases. In: H\u00f6llsberg P, Hafler DA, editors. Human T-cell lymphotropic virus type 1. John Willey & Sons Ltd.; 1996. p. 33\u201364."},{"key":"36_CR17","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","volume":"332","author":"O Hermine","year":"1995","unstructured":"Hermine O, et al. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alpha. N Engl J Med 1995;332:1749\u201351.","journal-title":"N Engl J Med"},{"key":"36_CR18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1099\/0022-1317-78-5-1007","volume":"78","author":"B Macchi","year":"1997","unstructured":"Macchi B, Faraoni I, Zhang J, Grelli S, Favalli C, Mastino A, et al. AZT inhibits the transmission of human T cell leukemia\/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro. J Gen Virol 1997;78:1007\u201316.","journal-title":"J Gen Virol"},{"key":"36_CR19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0168-1702(01)00285-4","volume":"78","author":"J Zhang","year":"2001","unstructured":"Zhang J, Balestrieri E, Grelli S, Matteucci C, Pagnini V, D\u2019Agostini C, et al. Efficacy of 3\u2032-azido 3\u2032deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells. Virus Res 2001;78:67\u201378.","journal-title":"Virus Res"},{"issue":"Suppl. 1","key":"36_CR20","first-page":"5186","volume":"R13","author":"A Bazarbachi","year":"1996","unstructured":"Bazarbachi A, Hermine O. Treatment with a combination of zidovudine and alpha-interferon in na\u00efve and pretreated adult T-cell leukemia\/lymphoma patients. J Acq Immun Defic Synd Hum 1996;R13(Suppl. 1):5186\u201390.","journal-title":"J Acq Immun Defic Synd Hum"},{"key":"36_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-4608(00)00337-X","volume":"124","author":"TC Hsu","year":"2001","unstructured":"Hsu TC, et al. Comparative efficacy as antioxidants between ascorbic acid and epigallocatechin gallate on cells of two human lymphoblastoid lines. Cancer Genet Cytogenet 2001;124:169\u201371.","journal-title":"Cancer Genet Cytogenet"},{"key":"36_CR22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1098-1128(199707)17:4<327::AID-MED2>3.0.CO;2-Y","volume":"17","author":"LA Mitscher","year":"1997","unstructured":"Mitscher LA, et al. Chemoprotection: a review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents. Med Res Rev 1997;17:327\u201365.","journal-title":"Med Res Rev"},{"key":"36_CR23","doi-asserted-by":"crossref","unstructured":"Yang CS, Yang GY, Landau JM, Kim S, Liao J. Exp Lung Res 1998;24:629.","DOI":"10.3109\/01902149809087391"},{"key":"36_CR24","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0024-3205(98)00406-8","volume":"63","author":"T Otsuka","year":"1998","unstructured":"Otsuka T, et al. Growth inhibition of leukemic cells by (-)-epigallocatechin gallate: the main constituent of green tea. Life Sci 1998;63:1397\u2013403.","journal-title":"Life Sci"},{"key":"36_CR25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0003-9861(02)00668-9","volume":"410","author":"S Gupta","year":"2003","unstructured":"Gupta S, Hussain T, Mukhtar H. Molecular pathway for (-)-epigallocatechin-3-gallate induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 2003;410:177\u201385.","journal-title":"Arch Biochem Biophys"},{"key":"36_CR26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/gast.2001.25544","volume":"121","author":"M Kanai","year":"2001","unstructured":"Kanai M, et al. TGF-\u03b1 inhibits apoptosis of murine gastric pit cells through an NF-\u03baB-dependent pathway. Gastroenterology 2001;121:56\u201367.","journal-title":"Gastroenterology"},{"key":"36_CR27","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S1357-2725(03)00255-3","volume":"36","author":"D Javelaud","year":"2004","unstructured":"Javelaud D, Mauviel A. Mammalian transforming growth factors-\u03b2s: Smad signaling and physio-pathalogical roles. Int J Biochem Cell Biol 2004;36:1161\u20135.","journal-title":"Int J Biochem Cell Biol"},{"key":"36_CR28","doi-asserted-by":"crossref","first-page":"38557","DOI":"10.1074\/jbc.M206786200","volume":"277","author":"DK Lee","year":"2002","unstructured":"Lee DK, et al. The human papilloma virus E7 oncoprotein inhibits transforming growth factor-\u03b2 signaling by blocking binding of the Smad complex to its target sequence. J Biol Chem 2002;277:38557\u201364.","journal-title":"J Biol Chem"},{"key":"36_CR29","first-page":"3","volume":"272","author":"K Saeki","year":"2000","unstructured":"Saeki K, et al. Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown soluble factor, is inhibited by transforming growth factor beta 1 and overexpression of Bcl-2. J Biol Chem 2000;272:3\u201310.","journal-title":"J Biol Chem"},{"key":"36_CR30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4049\/jimmunol.156.2.459","volume":"156","author":"A Cerwenka","year":"1996","unstructured":"Cerwenka A, Kovar H, Majdic O, Holter W. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1. J Immunol 1996;156:459\u201364.","journal-title":"J Immunol"},{"key":"36_CR31","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.188.10.1849","volume":"188","author":"W Chen","year":"1998","unstructured":"Chen W, Jin W, Wahl SM. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor \u03b2 (TGF-\u03b2) production by murine CD4+ T cells. J Exp Med 1998;188:1849\u201357.","journal-title":"J Exp Med"},{"key":"36_CR32","doi-asserted-by":"crossref","first-page":"38363","DOI":"10.1074\/jbc.M004861200","volume":"275","author":"S Patil","year":"2000","unstructured":"Patil S, et al. Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-\u03b2-induced growth inhibition and apoptosis. J Biol Chem 2000;275:38363\u201370.","journal-title":"J Biol Chem"},{"key":"36_CR33","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.4049\/jimmunol.165.5.2500","volume":"165","author":"GJ Inmann","year":"2000","unstructured":"Inmann GJ, Allday MJ. Apoptosis induced by TGF-\u03b21 in Burkitt\u2019s Lymphoma cells is caspase 8 dependent but is death receptor independent. J Immunol 2000;165:2500\u201310.","journal-title":"J Immunol"},{"key":"36_CR34","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.4049\/jimmunol.173.5.3093","volume":"173","author":"LA Wolfraim","year":"2004","unstructured":"Wolfraim LA, Walz TM, James Z, Fernandez T, Letterio JJ. p21Cip1 and p27Kip1 act in synergy of na\u00efve T cells to TGF-beta-mediated G1 arrest through modulation of IL-2 responsiveness. J Immunol 2004;173:3093\u2013102.","journal-title":"J Immunol"},{"key":"36_CR35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cytogfr.2004.11.002","volume":"16","author":"A S\u00e1nchez-Capelo","year":"2005","unstructured":"S\u00e1nchez-Capelo A. Dual role for TGF-\u03b21 in apoptosis. Cytokine Growth Factor Rev 2005;16:15\u201334.","journal-title":"Cytokine Growth Factor Rev"},{"key":"36_CR36","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1182\/blood-2001-12-0372","volume":"100","author":"B Arnulf","year":"2002","unstructured":"Arnulf B, et al. Human T-cell lymphotropic virus oncoprotein tax represses TGF-\u03b21 signaling in human T cells Via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis. Blood 2002;100:4129\u201337.","journal-title":"Blood"},{"key":"36_CR37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.immunol.16.1.137","volume":"16","author":"JJ Letterio","year":"1998","unstructured":"Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137\u201361.","journal-title":"Annu Rev Immunol"},{"key":"36_CR38","first-page":"M43","volume":"1471","author":"GP Dotto","year":"2000","unstructured":"Dotto GP. p21WAF1\/Cip1: more than a break to the cell cycle? Biochem Biophys Acta 2000;1471:M43\u201356.","journal-title":"Biochem Biophys Acta"},{"key":"36_CR39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1006\/jmbi.1999.2640","volume":"287","author":"NP Pavletich","year":"1999","unstructured":"Pavletich NP. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol 1999;287:821\u20138.","journal-title":"J Mol Biol"},{"key":"36_CR40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.dnarep.2004.03.027","volume":"3","author":"DW Meek","year":"2004","unstructured":"Meek DW. The p53 response to DNA damage. DNA Repair 2004;3:1049\u201356.","journal-title":"DNA Repair"},{"key":"36_CR41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.gde.2004.12.008","volume":"15","author":"X Lu","year":"2005","unstructured":"Lu X. p53: a heavily dictated dictator of life and death. Curr Opin Genet Dev 2005;15:27\u201333.","journal-title":"Curr Opin Genet Dev"},{"key":"36_CR42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2004.06.008","volume":"213","author":"S Dupont","year":"2004","unstructured":"Dupont S, et al. Convergence of p53 and TGF-beta signaling networks. Cancer Lett 2004;213:129\u201338.","journal-title":"Cancer Lett"},{"key":"36_CR43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.semcancer.2004.04.003","volume":"14","author":"S Haupt","year":"2004","unstructured":"Haupt S, Haupt Y. Manipulation of the tumor suppressor p53 for potentiating cancer therapy. Semin Cancer Biol 2004;14:244\u201352.","journal-title":"Semin Cancer Biol"},{"key":"36_CR44","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1038\/sj.onc.1203285","volume":"18","author":"P May","year":"1999","unstructured":"May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 1999;18:7621\u201336.","journal-title":"Oncogene"},{"key":"36_CR45","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.exger.2004.04.011","volume":"39","author":"D Heiser","year":"2004","unstructured":"Heiser D, Labi V, Erlacher M, Villunger A. The Bcl-2 protein family and its role in the development of neoplastic disease. Exp Gerontol 2004;39:1125\u201335.","journal-title":"Exp Gerontol"},{"key":"36_CR46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/path.1704","volume":"205","author":"G Lozano","year":"2005","unstructured":"Lozano G, Zambetti GP. What have animal models taught us about the p53 pathway? J Pathol 2005;205:206\u201320.","journal-title":"J Pathol"},{"key":"36_CR47","first-page":"219","volume":"10","author":"P Kuo","year":"2003","unstructured":"Kuo P, Lin CC. Green tea constituent (-)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways. J Biomed Sci 2003;10:219\u201327.","journal-title":"J Biomed Sci"},{"key":"36_CR48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ijc.20785","volume":"114","author":"M Nihal","year":"2005","unstructured":"Nihal M, Ahmad N, Mukhtar H, Wood GS. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. Int J Cancer 2005;114:513\u201321.","journal-title":"Int J Cancer"},{"key":"36_CR49","doi-asserted-by":"crossref","first-page":"3181S","DOI":"10.1093\/jn\/134.11.3181S","volume":"134","author":"CS Yang","year":"2004","unstructured":"Yang CS, Hong J, Hou Z, Sang S. Green tea polyphenols: antioxidative and prooxidative effects. J Nutr 2004;134:3181S.","journal-title":"J Nutr"},{"key":"36_CR50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10715760210161","volume":"36","author":"YT Szeto","year":"2002","unstructured":"Szeto YT, Benzie IFF. Effects of dietary antioxidants on human DNA ex vivo. Free Radic Res 2002;36:113\u20138.","journal-title":"Free Radic Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-0036-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-007-0036-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-0036-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T19:36:59Z","timestamp":1684006619000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-007-0036-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,14]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1007\/s12032-007-0036-6","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,14]]}}}